GV has participated in a series A round for Genomics Medicine Ireland, joining investors such as the government-owned Ireland Strategic Investment Fund.

Ireland-based life sciences company Genomics Medicine Ireland (GMI) received $40m in series A funding yesterday from a consortium including GV, the corporate venturing arm of internet and technology conglomerate Alphabet. The round also featured venture capital firms Arch Venture Partners and Polaris Partners as well as the Ireland Strategic Investment Fund, an $8.1bn vehicle managed…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.